Zydus Lifesciences posted a 26.6% drop in second-quarter net profit to 9.26 billion rupees ($97.77 million) on Wednesday morning. Operating expenses surged 51%, outpacing a 29.2% increase in total revenue to 79.10 billion rupees. The margin squeeze pushed shares down 4% during the trading session.

Rising Expenses Overshadow Revenue Growth